Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term chemically induced. Found 71 abstracts

no pagination
Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu TE, Badin F, Ready N, Hiltermann TJ, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA, CheckMate I. First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. The New England journal of medicine. 2017 Jun 22;376(25):2415-26.   PMCID: Comment
Moore KN, Martin LP, O'Malley DM, Matulonis UA, Konner JA, Perez RP, Bauer TM, Ruiz-Soto R, Birrer MJ. Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. J Clin Oncol. 2017 Apr;35(10):1112-8.   PMCID: PMC5559878
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.   PMCID: Review
Virtue A, Johnson C, Lopez-Pastrana J, Shao Y, Fu H, Li X, Li YF, Yin Y, Mai J, Rizzo V, Tordoff M, Bagi Z, Shan H, Jiang X, Wang H, Yang XF. MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease: A NOVEL MOUSE MODEL OF OBESITY PARADOX. The Journal of biological chemistry. 2017 Jan 27;292(4):1267-87.   PMCID: PMC5270472
Aaron H, Azadarmaki R, Lango MN. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review. Am J Ther. 2016 Mar;23(2):e621-3.
Alvarez P, Jensen LE. Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner. Mediators of inflammation. 2016 Jan;2016:6756138.   PMCID: PMC5183767
Burtness B, Powell M, Catalano P, Berlin J, Liles DK, Chapman AE, Mitchell E, Benson AB. Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study. Am J Clin Oncol. 2016 Aug;39(4):340-5.   PMCID: PMC4177955
Finnberg NK, Gokare P, Navaraj A, Lang Kuhs KA, Cerniglia G, Yagita H, Takeda K, Motoyama N, El-Deiry WS. Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity. Cancer Res. 2016 Feb;76(3):700-12.   PMCID: PMC5001853
Fu X, Ju J, Lin Z, Xiao W, Li X, Zhuang B, Zhang T, Ma X, Li X, Ma C, Su W, Wang Y, Qin X, Liang S. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice. Sci Rep. 2016 Jul 22;6:30239.   PMCID: PMC4957234
Rowley JW, Chappaz S, Corduan A, Chong MM, Campbell R, Khoury A, Manne BK, Wurtzel JG, Michael JV, Goldfinger LE, Mumaw MM, Nieman MT, Kile BT, Provost P, Weyrich AS. Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets. Blood. 2016 Apr 07;127(14):1743-51.   PMCID: PMC4825412
Bassi DE, Cenna J, Zhang J, Cukierman E, Klein-Szanto AJ. Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6). Mol Carcinog. 2015 Oct;54(10):1122-31.   PMCID: PMC4240754
Cheung M, Kadariya Y, Pei J, Talarchek J, Facciolo F, Visca P, Righi L, Cozzi I, Testa JR, Ascoli V. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation. Cancer Genet. 2015 Oct;208(10):502-7.   PMCID: PMC4608746
Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. The New England journal of medicine. 2015 Mar 05;372(10):923-32.   PMCID: 4405231
Neelakantan H, Ward SJ, Walker EA. Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57Bl/6 mice. Exp Clin Psychopharmacol. 2015 Aug;23(4):217-27.
Shah JJ, Stadtmauer EA, Abonour R, Cohen AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT, Gomes CL, Pascucci N, Smith DD, Orlowski RZ, Durie BG. Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. Blood. 2015 Nov 12;126(20):2284-90.   PMCID: PMC4643003
Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. The New England journal of medicine. 2015 Aug 20;373(8):737-46.   PMCID: 4562797
Zhang Y, Dun SL, Chen YH, Luo JJ, Cowan A, Dun NJ. Scratching activates microglia in the mouse spinal cord. J Neurosci Res. 2015 Mar;93(3):466-74.   PMCID: PMC4293236
Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol. 2014 Apr 20;32(12):1210-7.   PMCID: Pmc3986384
Infante JR, Dees EC, Olszanski AJ, Dhuria SV, Sen S, Cameron S, Cohen RB. Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol. 2014 Oct;32(28):3103-10.
Mateo J, Berlin J, de Bono JS, Cohen RB, Keedy V, Mugundu G, Zhang L, Abbattista A, Davis C, Gallo Stampino C, Borghaei H. A first-in-human study of the anti-alpha5beta1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors. Cancer Chemother Pharmacol. 2014 Nov;74(5):1039-46.   PMCID: Pmc4209234
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term chemically induced

chemically induced adverse effects Female drug therapy pathology metabolism Male Adult Middle Aged therapeutic use Mice Aged Disease-Free Survival Antineoplastic Agents 80 and over Aged genetics Monoclonal Antibodies-Humanized Antineoplastic Combined Chemotherapy Protocols pharmacology administration & dosage drug effects Animal Disease Models Diarrhea Knockout Mice Drug Dose-Response Relationship Taxoids immunology Neoplasms mortality analogs & derivatives Nausea Tumor Cell Line Hypotension antagonists & inhibitors Gastrointestinal Diseases MicroRNAs blood Inbred C57BL Mice toxicity Monoclonal Antibodies Drug Administration Schedule Area Under Curve Transgenic Mice Lung Neoplasms Treatment Outcome Inflammation Pain Measurement CD274 Antigens physiology prevention & control Pulmonary Embolism agonists Fatigue Response Evaluation Criteria in Solid Tumors chemistry pharmacokinetics Ovarian Neoplasms Kaplan-Meier Estimate Sex Characteristics Apoptosis Intravenous Infusions Anticoagulants Inflammasomes Pcsk6 Bone Neoplasms Inhibitor of Apoptosis Proteins Immune-related adverse events cancer predisposition Up-Regulation Complement Membrane Attack Complex Ubiquitin Thiolesterase Hemolysis Acute Pain Mutation Tablets Interleukin-1 Type I Receptors Shock Melanoma proprotein convertases Maximum Tolerated Dose Skin Neoplasms Acetic Acid epidemiology Proprotein Convertases itch Ewing Sarcoma Pregnancy Rate CA-19-9 Antigen Camptothecin Disease Progression p38 Mitogen-Activated Protein Kinases surgery bezo(a)pyrene Interleukin-1 Complement C9 nalfurafine skin carcinogenesis Carcinogenesis induced Breast Neoplasms Pharmaceutical Solutions IGF Type 1 Receptor secretion obesity Fallopian Tube Neoplasms Nivolumab Cell Line Argonaute Proteins liver glia CTLA-4 Antigen Non-Small-Cell Lung Carcinoma Asbestos Oligonucleotide Array Sequence Analysis use Carcinogens Integrin alpha2 Complement C5b Pancreatic Neoplasms p-Methoxy-N-methylphenethylamine Metabolic Clearance Rate deficiency Young Adult Prostatic Neoplasms p38 Follow-Up Studies Complement System Proteins Premenopause squamous cell carcinoma Morphinans Spinal Cord therapy Enoxaparin etiology DEAD-box RNA Helicases Oligopeptides biosynthesis Erythrocytes Post-Transcriptional RNA Processing Guanidines cytology Biological Availability Analysis of Variance therapeutic adverse Phosphorylation compound 48 physiopathology Vocal Cord Paralysis Oral Administration
Last updated on Friday, January 03, 2020